Prostate Cancer Research Inc
Dover, Delaware
FHealth Score
18F
Financial Health Score
8-metric score across financial health, operational efficiency, and resilience. Based on IRS Form 990 filing data.
Insufficient Data
💰
$23K
Total Revenue
📊
$421K
Total Expenses
🏦
-$723K
Net Assets
📋
$753K
Total Liabilities
Financial Trends
5-Year Trend Analysis
Financial Health Indicators
Net Margin
-1754.5%
Revenue minus expenses as % of revenue
Working Capital Ratio
-1.72
Net assets divided by total expenses
Liabilities-to-Assets
2465.3%
Total liabilities as % of total assets
Filing History
3 filings on record| Year | Revenue | Expenses | Assets | |
|---|---|---|---|---|
| 2023 | $22,687 | $420,739↑43% | $30,551↑5% | — |
| 2022 | $0↓100% | $293,728↑64% | $29,232↑71% | — |
| 2021 | $33,109 | $179,095 | $17,070 | — |
Frequently Asked Questions
What does Prostate Cancer Research Inc do?▼
Prostate Cancer Research Inc is a medical research nonprofit organization based in Delaware. It is classified under NTEE code H40 and is registered as a 501(c) tax-exempt organization with the IRS.
Is Prostate Cancer Research Inc financially healthy?▼
Financial health scoring requires Form 990 filing data. Check back as we process more filings for Prostate Cancer Research Inc.
How much revenue does Prostate Cancer Research Inc generate?▼
Prostate Cancer Research Inc reports $23K in annual revenue and holds $31K in total assets, based on IRS filings.
Similar Organizations
Explore more organizations in the Medical Research category, or browse all nonprofits in Delaware.